Very poor long-term outcomes for people with TB and HIV in Eastern Europe
Oral six-month treatment for MDR-TB is safe and effective in people with HIV
Shorter, less toxic treatment for highly drug-resistant TB cures nine out of ten
EACS Standard of Care meeting report – Tackling HIV and co-infections in Europe: towards common standards
Glimmers of hope: moving towards better HIV and TB treatment in eastern Europe
Treatment with bedaquiline significantly reduces mortality among South African people with XDR- and MDR-TB
MDR-TB numbers could keep growing despite improved treatment
Three-drug regimen beats XDR-TB in first trial
Shortened regimen for MDR-TB shows good results for children
